The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease

被引:41
作者
Zou, Yu-Qiong [1 ]
Lu, Liang-Jing [1 ]
Li, Shu-Jie [1 ]
Zeng, Ting [1 ]
Wang, Xiao-Dong [1 ]
Bao, Chun-De [1 ]
Chen, Shun-Le [1 ]
Yang, Cheng-De [1 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Rheumatol, Shanghai 200001, Peoples R China
基金
中国国家自然科学基金;
关键词
macrophage migration inhibitory factor; adult-onset Still's disease;
D O I
10.1016/j.clinbiochem.2008.01.008
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: This study investigated the levels of macrophage migration inhibitory factor (MIF) in adult-onset Still's disease (AOSD) and explored the role of this pro-inflammatory cytokine in the systemic inflammation of AOSD. Design and methods: Serum MIF levels were measured by ELISA in patients with AOSD and controls. Intracellular MIF production by peripheral blood leukocytes was detected by three-color flow cytometry. Results: Serum MIF levels were significantly increased in patients with AOSD. Serum MIF levels were significantly higher in AOSD patients with sore throat, myalgias, splenomegaly, or pleuritis, and were closely correlated with clinical disease severity and activity. Examined by flow cytometry, the intracellular MIF levels ill monocytes and T-lymphocytes from AOSD patients were significantly higher than those from healthy subjects. Conclusion: These data represent the first demonstration of increased MIF expression in AOSD, and suggest that MIF may be all important marker for disease evaluation and monitoring. (c) 2008 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:519 / 524
页数:6
相关论文
共 39 条
[11]   Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome [J].
Donnelly, SC ;
Haslett, C ;
Reid, PT ;
Grant, IS ;
Wallace, WAH ;
Metz, CN ;
Bruce, LJ ;
Bucala, R .
NATURE MEDICINE, 1997, 3 (03) :320-323
[12]   Diagnosis and management of adult onset Still's disease [J].
Efthimiou, P ;
Paik, PK ;
Bielory, L .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (05) :564-572
[13]   Pathogenesis and management of adult-onset Still's disease [J].
Efthimiou, Petros ;
Georgy, Sharon .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2006, 36 (03) :144-152
[14]   Ferritin levels in adult Still's disease: any sugar? [J].
Fautrel, B .
JOINT BONE SPINE, 2002, 69 (04) :355-357
[15]  
Foote A, 2004, J RHEUMATOL, V31, P268
[16]   Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease [J].
Fujii, T ;
Nojima, T ;
Yasuoka, H ;
Satoh, S ;
Nakamura, K ;
Kuwana, M ;
Suwa, A ;
Hirakata, M ;
Mimori, T .
RHEUMATOLOGY, 2001, 40 (12) :1398-1404
[17]  
Hoshino T, 1998, J RHEUMATOL, V25, P396
[18]   Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody/lipopolysaccharide (LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF) [J].
Ichiyama, H ;
Onodera, S ;
Nishihira, J ;
Ishibashi, T ;
Nakayama, T ;
Minami, A ;
Yasuda, K ;
Tohyama, H .
CYTOKINE, 2004, 26 (05) :187-194
[19]   Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease [J].
Isidori, AM ;
Kaltsas, GA ;
Korbonits, M ;
Pyle, M ;
Gueorguiev, M ;
Meinhardt, A ;
Metz, C ;
Petrovsky, N ;
Popovic, V ;
Bucala, R ;
Grossman, AB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) :1834-1840
[20]   Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1 [J].
Kleemann, R ;
Hausser, A ;
Geiger, G ;
Mischke, R ;
Burger-Kentischer, A ;
Flieger, O ;
Johannes, FJ ;
Roger, T ;
Calandra, T ;
Kapurniotu, A ;
Grell, M ;
Finkelmeier, D ;
Brunner, H ;
Bernhagen, J .
NATURE, 2000, 408 (6809) :211-216